Research

Area 3

Gastrointestinal and pancreatic oncology

Team leader

Strategic objectives

The gaining of in-depth knowledge of the mechanisms underlying the development and progression of gastrointestinal and pancreatic premalignant and malignant lesions, with a view to defining new diagnostic, therapeutic and/or preventive strategies.

Main lines of research

The activity of the research group in gastrointestinal and pancreatic oncology is divided into four areas, and these in turn correspond to different lines of investigation:

1. Physiopathology of colorectal cancer:
  • Hereditary forms of colorectal cancer, screening and vigilance.
  • Genetic susceptibility in colorectal cancer.
  • Epigenetics of colorectal cancer.
2. Physiopathology of pancreatic cancer:
  • Implication of microRNAs in pancreatic cancer.
  • Epithelial-mesenchymal transition in the local and metastatic spread of pancreatic cancer.
3.Research and innovation in endoscopy:
  • Endoscopic ultrasound.
  • Advanced diagnostic techniques.
  • Endoscopic therapies.
4. Research and innovation in surgery:
  • Surgery for colorectal cancer.
  • Surgery for pancreatic cancer.